Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 30 2014
Print

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published February 26, 2013
Baxter International Inc.'s BioPharma Solutions business has begun an approximately 1,750 square meter capacity expansion at the company's fill/finish cytotoxic contract manufacturing facility in Halle (Westfalen), Germany. The facilit… Read More »
Published February 3, 2012
Will initially produce clinical batches for eight clinical trial sites Read More »
By Gil Roth
Published January 17, 2012
Will work on DNA minor groove binder Read More »
Published August 18, 2011
Commercial sale of Phoslyra triggers $5M payment Read More »
Published March 28, 2011
Peter S. Linsley, Ph.D., has been appointed chief scientific officer of AVI BioPharma, Inc., effective May 1, 2011. Read More »
Published February 8, 2010
When is a la carte a better option? Read More »
Biopharma CMO Market Report
By William Downey
Published May 1, 2009
Optimism remains high among bio-contract manufacturers Read More »
Published August 20, 2008
Bristol-Myers Squibb and PDL BioPharma, Inc. entered an agreement for the global development and commercialization of PDL’s anti-CS1 antibody, elotuzumab, currently in Phase I development for multiple myeloma.     Elotuzumab o… Read More »
Published February 5, 2008
A recent study by the Tufts Center for the Study of Drug Development found that how drug developers organize their companies affects operational and financial performance. The research, developed by Tufts CSDD and PRTM, an operations management consu… Read More »
Published September 21, 2005
The Top 10 Biopharma rankings saw two more companies reach the billion-dollar mark in revenues in 2004, as Gilead and MedImmune crossed that threshold. Unfortunately, a bad case of the flu sent Chiron back under the billion-dollar mark, as its fluvirin vaccine revenues dropped from $219 million in 2003 to a mere $2 million last year, after its well-documented manufacturing problems. Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On